Recent Developments in Orthopaedic Implants

Introduction

1. Evolution of Biomaterials

1.1 Traditional Metals - Continued Refinements

• Beta-titanium alloys (Ti-Nb, Ti-Mo) with lower elastic modulus (~55 GPa vs 110 GPa for standard Ti-6Al-4V), reducing stress shielding and cortical bone atrophy
• Nanostructured titanium via severe plastic deformation achieves higher surface energy, improved osteoblast adhesion, and superior osseointegration without altering bulk mechanical properties

1.2 Biodegradable Metals - The New Frontier

• Naturally degrade by corrosion in physiological fluids
• Elastic modulus (41-45 GPa) is closer to bone than steel or titanium - reducing stress shielding
• Release Mg²⁺ ions that are osteopromotive and stimulate osteogenesis
• Main challenge: rapid corrosion causing premature mechanical failure and hydrogen gas evolution. Solved by alloying with zinc, calcium, strontium, and rare earth elements (e.g., Mg-Zn-Ca, WE43 alloy), and by applying surface coatings (micro-arc oxidation, polymer coatings)
• Clinical applications: paediatric fracture fixation, cancellous bone screws, interference screws for ligament reconstruction

• Slower degradation rate than magnesium (more controllable)
• Highly biocompatible - zinc is the second most common trace mineral in the body
• Already used in cardiovascular stents; orthopaedic applications expanding
• Zn²⁺ has antimicrobial properties - a built-in infection defence

• Very slow degradation (may be too slow for some applications)
• Mechanical strength approaching stainless steel
• Research ongoing to accelerate degradation rate via porosity and alloying

1.3 Polymers and Composites

• Radiolucent - allows unobstructed imaging assessment of fusion/healing
• Elastic modulus closer to cortical bone (~4 GPa) than metals
• Weakness: bioinert surface causes poor osseointegration. Solutions include surface functionalization, HA-coating of PEEK surfaces, and carbon-fibre reinforced PEEK (CF-PEEK) for spinal cages

• Highly cross-linked UHMWPE (HXLPE) with Vitamin E stabilization has dramatically reduced wear debris in total hip and knee arthroplasty
• Second-generation formulations (antioxidant-stabilized HXLPE) maintain fatigue resistance while eliminating oxidative embrittlement

• Alumina and Zirconia ceramic heads - superior scratch resistance, very low wear rates in ceramic-on-ceramic bearings (e.g., Biolox Delta)
• Hydroxyapatite (HA) - chemical composition mimics bone mineral; used as coating rather than bulk material due to brittleness
• Tricalcium phosphate (TCP) - resorbable filler for bone defects

• Nanoparticle-reinforced polymer and ceramic matrices achieve simultaneously improved strength and toughness
• Carbon nanotube-reinforced composites show promise for bone tissue engineering scaffolds

2. Additive Manufacturing (3D Printing) in Orthopaedic Implants

2.1 Technologies Used

2.2 Porous Architecture and Osseointegration

• 3D printing creates trabecular-like porous scaffolds (pore size 400-800 µm, porosity 60-80%) mimicking cancellous bone architecture
• Pores allow bone ingrowth, vascularization, and nutrient transport - far superior to smooth-surfaced implants
• Gradient porosity: denser core for mechanical strength, porous periphery for biological integration
• Clinical examples: porous titanium spinal fusion cages, acetabular cups with trabecular metal design (Zimmer Biomet TM Cups), revision knee implants

2.3 Patient-Specific Implants (PSI)

• CT/MRI data segmented to create 3D model of patient anatomy
• Implants manufactured to exact anatomical dimensions - crucial for:
  • Complex pelvic tumour reconstructions (hemipelvis replacement)
  • Revision arthroplasty with massive bone loss
  • Mandibular/craniofacial reconstruction
  • Shoulder arthroplasty in severe glenoid deformity
• Reduces operative time, improves fit, enhances outcomes in complex cases

2.4 Surgical Guides and Planning

• Patient-specific cutting guides (PSG) and drill guides improve accuracy in osteotomy and implant placement
• 3D-printed anatomical models used for pre-surgical simulation, patient consent, and training

3. Surface Engineering and Coatings

3.1 Bioactive Coatings for Osseointegration

• Plasma spray deposition of HA onto titanium creates a biologically active surface
• HA is chemically similar to bone mineral; osteoblasts preferentially adhere and proliferate
• Plasma-sprayed HA cementless acetabular cups and femoral stems are standard in cementless hip arthroplasty
• Latest development: nano-HA coatings (nanoscale HA particles) achieve higher surface area and superior cell adhesion compared to conventional HA coatings

• Strontium substitution enhances osteogenesis and reduces osteoclast activity
• Silicon substitution improves bioactivity and dissolution kinetics

• Bond chemically to both bone and soft tissue
• Release silicate ions that upregulate osteogenic gene expression

• Sandblasting and acid-etching (SLA) creates a micro-rough surface maximizing contact area
• Anodization and plasma electrolytic oxidation (PEO) create nanoporous oxide layers enhancing protein adsorption and cell attachment
• Laser surface texturing creates precise micro/nano patterns directing cell orientation

3.2 Antibacterial and Anti-Infective Coatings

• Silver ions have broad-spectrum antimicrobial activity against S. aureus, E. coli, MRSA, and Pseudomonas
• Ag-NP coated titanium surfaces show dramatically reduced bacterial adhesion and biofilm formation in vitro and in animal models
• Concern: cytotoxicity at high concentrations requires controlled, sustained release designs

• Gentamicin-coated intramedullary nails (GENAX nail, Synthes) for open tibial fractures showed significant reduction in deep infection rates in clinical trials - now entering routine use
• Vancomycin-coated implants for high-risk situations (revision, immunocompromised patients)
• Controlled drug release achieved via polymer carrier matrices (PLGA, fibrin, calcium phosphate)

• Zwitterionic polymer coatings resist protein adsorption (antifouling), preventing the initial bacterial adherence step
• Bacteriophage-functionalized surfaces - lytic phages immobilized on implant surface that selectively destroy specific bacterial species
• Nitric oxide releasing coatings - exploit NO's natural role as an antimicrobial signalling molecule

4. Nanotechnology in Orthopaedic Implants

• Nanostructured surfaces mimic natural bone matrix at the molecular scale, enhancing protein adsorption, osteoblast differentiation, and osseointegration
• Nanoparticle drug delivery - nanoparticles (PLGA, liposomes, mesoporous silica) loaded into implant coatings provide sustained local release of growth factors (BMP-2, BMP-7), bisphosphonates (to prevent periprosthetic bone loss), or antibiotics
• Carbon nanotubes (CNTs) - remarkable mechanical properties (tensile strength 100x steel), being incorporated into polymer matrices for scaffolds; also function as drug carriers and electrical conduits for bone stimulation
• Graphene-based materials - graphene oxide incorporated into implant coatings improves mechanical strength, electrical conductivity (useful for bone electrostimulation), and antimicrobial properties
• Quantum dots - fluorescent nanoparticles under investigation for real-time imaging of implant integration and tissue healing

5. Smart Implants and Connected Care

5.1 Embedded Sensors

• Strain gauges / piezoresistive sensors - measure bending moments and axial loads on the implant; used to track fusion progression in spinal surgery (load decreases as bone fusion occurs) and fracture healing
• Piezoelectric sensors - generate electricity from mechanical deformation; provide both sensing and energy harvesting capabilities
• Pressure sensors - in knee and hip arthroplasty, measure joint contact pressures intraoperatively (e.g., VERASENSE knee sensor, OrthoSensor) and postoperatively
• Accelerometers - detect patient activity, gait patterns, fall detection
• Temperature sensors - early detection of periprosthetic infection (elevated local temperature precedes clinical signs)

5.2 Wireless Telemetry and Energy Harvesting

• Data transmission via Bluetooth Low Energy (BLE) or near-field communication (NFC)
• Energy harvested from body movement (piezoelectric), body heat (thermoelectric), or inductive charging transcutaneously - eliminating battery replacement surgery
• Real-time data sent to smartphone app or clinical portal - allows remote monitoring of:
  • Implant loading patterns
  • Patient weight-bearing compliance during rehabilitation
  • Early signs of loosening or infection
  • Fusion progression (spinal and fracture surgery)

5.3 Clinical Applications

• Smart tibial tray (total knee arthroplasty) - force sensors measure compartmental loading; helps balance flexion-extension gaps intraoperatively and monitors function post-operatively
• Instrumented spinal rods - strain-sensor equipped posterior rods; SMART spinal implants in 34 clinical/cadaveric studies quantified posture-dependent spinal loading (Khodaee et al., 2026 systematic review)
• Smart fracture fixation plates - real-time load-sharing data guides rehabilitation progression

6. Artificial Intelligence and Implant Design

• Generative design algorithms - AI optimizes implant geometry for specific loading conditions, creating lattice structures impossible to design manually, maximising strength-to-weight ratio
• Machine learning for failure prediction - analysis of patient variables (bone density, body weight, anatomy, activity level) to predict optimal implant size, design, and fixation method
• Finite element analysis (FEA) simulation - AI-accelerated FEA models allow rapid virtual testing of custom implants before fabrication
• Image segmentation - automated CT/MRI segmentation for patient-specific implant design workflow
• Predictive analytics - AI models predict implant survival, readmission risk, and rehabilitation milestones from preoperative data

7. Robotic-Assisted Implantation

• Active systems (MAKO, Stryker) - robotic arm executes the surgical plan autonomously within defined limits; used for unicompartmental and total knee arthroplasty, total hip arthroplasty
• Haptic feedback systems - constrain the surgeon to safe anatomical zones
• Improved component positioning - acetabular cup inclination/anteversion, tibial slope - reduces wear, dislocation, and instability
• MAKO TKA studies show improved component positioning accuracy, reduced outliers, and superior short-term patient-reported outcomes compared to conventional instrumentation

8. Biodegradable and Bioresorbable Implants

• PLLA (Poly-L-Lactic Acid), PGA (Polyglycolic Acid), PLGA - established for soft tissue anchors, interference screws
• Newer materials: PLDLA (poly-L-DL-lactic acid) with improved degradation profiles
• Bioresorbable orthopaedic screws now used for:
  • Paediatric fracture fixation (avoid growth plate damage and hardware removal)
  • Osteochondral lesion fixation
  • Ligament and tendon reattachment (interference screws)
• Limitation: current materials inferior to metals in mechanical strength for load-bearing situations

9. Tissue Engineering and Biological Implants

• Scaffolds + cells + growth factors - the triad of tissue engineering
• Bone morphogenetic proteins (BMP-2, BMP-7) - recombinant BMPs delivered via collagen sponge or implant coating to enhance spinal fusion and fracture healing; already FDA-approved (Infuse, Medtronic)
• Cell-seeded scaffolds - mesenchymal stem cells (MSCs) seeded onto porous scaffolds; differentiate into osteoblasts and chondrocytes under appropriate signals
• Cartilage regeneration - matrix-induced autologous chondrocyte implantation (MACI), osteochondral scaffolds (Agili-C, CartiHeal) for focal cartilage defects
• Decellularized bone allografts - processed to remove immunogenic cellular material, retaining ECM scaffold; reconstituted with patient's own cells

10. Future Directions

Summary Table - Key Developments at a Glance

Conclusion

• Misir A. Current developments in orthopaedic implant technology. J Orthop Surg Res. 2025;20:927 - comprehensive 2020-2025 review
• Khodaee M et al. SMART Implantable Devices for Spinal Implants. Sensors. 2026;26:2729 - systematic review of smart spinal implants
• Cong B, Zhang H. 3D printing technologies in orthopedic surgery. Front Bioeng Biotechnol. 2025 - comprehensive 3D printing review
• Kumar R et al. Integrating AI in Orthopedic Care. Bioengineering. 2025 - AI in orthopaedics

Autologous Blood Transfusion

Definition

Advantages of ABT over Allogeneic Transfusion

Types of Autologous Blood Transfusion

1. Pre-Deposit Autologous Donation (PAD)

• Each session collects 1-2 units of whole blood
• Can be repeated weekly; typically up to 4 units maximum due to limited storage time (35-42 days for packed RBCs)
• Haemoglobin must remain above 11 g/dL before each donation
• Last donation should be no less than 28 days before surgery - donation closer to surgery causes preoperative anaemia that impairs perioperative tolerance
• Technically possible up to 72 hours pre-operatively, but not recommended

• Erythropoietin (EPO) - stimulates erythropoiesis, allows more repeat donations and corrects donation-induced anaemia; most effective adjunct
• Iron supplementation - indicated only in iron-deficient patients; not helpful in iron-replete individuals

• Patients with rare blood types or multiple alloantibodies where compatible allogeneic blood is difficult to source
• Patients who refuse allogeneic blood on religious grounds (Jehovah's Witnesses will sometimes accept their own pre-deposited blood if the circuit remains unbroken - though practices vary)
• High expected blood loss procedures: total hip arthroplasty (THA), total knee arthroplasty (TKA), spinal fusion, liver resection

• Bacteraemia or active infection (risk of contaminating stored unit)
• Cardiovascular instability (angina, severe aortic stenosis) - cannot tolerate donation-induced anaemia
• Procedures at risk of postponement - stored units expire and are wasted
• PAD units cannot be used by the general blood supply (not subjected to standard donor testing)
• Wastage rate up to 45% - major reason for declining use; patients should not be transfused autologous blood merely to avoid wastage; transfusion thresholds must still be respected

• Clerical error (wrong unit to wrong patient)
• Transfusion-associated circulatory overload (TACO)
• Bacterial contamination of stored unit
• Metabolic derangements of stored blood (hyperkalaemia, acidosis)
• Transfusion-related immunomodulation (TRIM) - to a lesser extent

2. Acute Normovolaemic Haemodilution (ANH)

Allowable Blood Loss = EBV × (H₀ - Hf) / Hav

• No preoperative anaemia
• Blood is fresh whole blood - contains functional platelets and clotting factors (unlike stored PAD units or cell-salvaged packed RBCs)
• No risk of clerical error if blood stays with the patient
• No storage costs
• Performed in the operating theatre - simple and cheap
• Effective in cardiac, orthopaedic, and spinal surgery

• Severe anaemia (Hb <10 g/dL) - no reserve to dilute
• Haemodynamic instability
• Significant coronary artery disease or poor cardiac reserve - cannot tolerate haemodilution
• Coagulopathy
• Renal or hepatic insufficiency
• Hypoalbuminaemia

3. Perioperative Blood Cell Salvage (Intraoperative Blood Salvage - IOBS)

1. Suction system - collects shed blood with anticoagulant (heparin or citrate) mixed at the suction tip
2. Reservoir / filter - holds collected blood; removes debris and fat
3. Centrifuge bowl - separates RBCs from plasma, platelets, anticoagulant, fat emboli, activated clotting factors, cellular debris
4. Washing system - saline washes remove contaminants
5. Re-infusion bag - processed washed RBCs (haematocrit 50-80%) ready for re-infusion

• Total hip and knee arthroplasty (primary and revision)
• Spinal surgery with instrumentation - a 2025 systematic review confirms IOBS significantly reduces allogeneic transfusion in paediatric and adult spinal deformity surgery (Feuer et al., Spine Deform 2025)
• Pelvic fractures and acetabular reconstruction
• Long bone tumour surgery
• Pathological fractures

• No storage-related complications - cells re-infused are fresh
• Effective in high-volume blood loss procedures
• Cost-effective vs allogeneic transfusion in procedures with >500 mL expected loss
• Reduces allogeneic transfusion dependency
• Suitable for Jehovah's Witnesses when circuit is kept continuous
• No risk of transfusion-transmitted infection

• Malignant tumours - risk of disseminating cancer cells (relative; can use leucocyte depletion filters; used selectively)
• Bowel contamination of operative field - bacterial seeding into salvaged blood
• Amniotic fluid contamination - risk of amniotic fluid embolism (relative contraindication; leucocyte filters reduce risk)
• Sickle cell disease (relative)
• Use of topical haemostatic agents (e.g., thrombin, hydrogen peroxide) in field that would contaminate salvage

• Blood collected from postoperative drains (up to 6 hours) in a reservoir
• Either reinfused directly or after washing
• Used in TKA and THA
• Evidence for efficacy is weaker than IOBS; blood collected may contain inflammatory mediators, fat globules, and activated complement

Comparison of Three Methods

Role in Orthopaedic Practice

• Total Hip Arthroplasty - expected loss 500-1500 mL; PAD + IOBS both used
• Total Knee Arthroplasty - tourniquet reduces operative loss; postoperative salvage from drain most relevant
• Revision Arthroplasty - higher blood loss; IOBS strongly indicated
• Spinal instrumentation (scoliosis correction, lumbar fusion) - IOBS standard of care
• Pelvic/acetabular fractures - intraoperative salvage highly effective
• Bone tumour surgery - IOBS with leucocyte filter for some cases

Current Position

• No preoperative anaemia induction
• No blood wastage
• Fresh cells (better oxygen-carrying capacity)
• Comparable or superior blood conservation
• More cost-effective per transfusion avoided

• Barash, Cullen & Stoelting's Clinical Anesthesia, 9th ed., p. 1330-1331
• Sain A et al. Cell Salvager in Orthopaedic Surgery. Georgian Med News 2024 (PMID 39580825)
• Feuer G et al. Intraoperative cell salvage in spinal surgery. Spine Deform 2025 (PMID 40465098)

Autologous Blood Transfusion

Definition

Advantages of ABT over Allogeneic Transfusion

Types of Autologous Blood Transfusion

1. Pre-Deposit Autologous Donation (PAD)

• Each session collects 1-2 units of whole blood
• Can be repeated weekly; typically up to 4 units maximum (storage limit 35-42 days for packed RBCs)
• Haemoglobin must remain above 11 g/dL before each donation
• Last donation should be no less than 28 days before surgery - donation closer to surgery causes preoperative anaemia that impairs perioperative tolerance
• Technically possible up to 72 hours pre-operatively, but not recommended

• Erythropoietin (EPO) - stimulates erythropoiesis, allows repeat donations and corrects donation-induced anaemia; most effective adjunct
• Iron supplementation - indicated only in iron-deficient patients; not helpful in iron-replete individuals

• Patients with rare blood types or multiple alloantibodies where compatible allogeneic blood is difficult to source
• Patients who refuse allogeneic blood on religious grounds
• High expected blood loss procedures: THA, TKA, spinal fusion, liver resection

• Bacteraemia or active infection (contamination of stored unit)
• Cardiovascular instability - cannot tolerate donation-induced anaemia
• Procedures at risk of postponement - stored units expire and are wasted
• PAD units cannot be used by the general blood supply if not transfused
• Wastage rate up to 45% - major reason for declining use; transfusion thresholds must still be respected (patients must NOT be transfused simply to avoid wastage)

• Clerical error (wrong unit to wrong patient)
• Transfusion-associated circulatory overload (TACO)
• Bacterial contamination of stored unit
• Metabolic derangements of stored blood (hyperkalaemia, acidosis)

2. Acute Normovolaemic Haemodilution (ANH)

ABL = EBV × (H₀ - Hf) / Hav (EBV = estimated blood volume; H₀ = starting haematocrit; Hf = minimum acceptable haematocrit; Hav = average of H₀ and Hf)

• No preoperative anaemia induction
• No storage costs or wastage
• Simple, cheap, performed in theatre
• No risk of clerical error if blood stays with patient throughout

• Severe anaemia (Hb <10 g/dL) - no reserve to dilute
• Haemodynamic instability
• Significant coronary artery disease / poor cardiac reserve
• Coagulopathy, renal or hepatic insufficiency
• Hypoalbuminaemia

3. Perioperative Blood Cell Salvage (Intraoperative Blood Salvage - IOBS)

1. Suction system - collects shed blood with anticoagulant (heparin or citrate) at suction tip
2. Reservoir/filter - holds blood, removes gross debris and fat
3. Centrifuge bowl - separates RBCs from plasma, platelets, anticoagulant, fat, and activated clotting factors
4. Washing system - saline wash removes contaminants
5. Re-infusion bag - washed RBCs at haematocrit 50-80%, ready for re-infusion

• Total hip and knee arthroplasty (primary and especially revision)
• Spinal instrumentation / scoliosis correction - a 2025 systematic review confirms IOBS significantly reduces allogeneic transfusion in spinal deformity surgery
• Pelvic fractures and acetabular reconstruction
• Long bone tumour surgery
• Major trauma

• No storage-related complications - cells are fresh
• No wastage
• Highly effective in high-volume blood loss procedures
• Cost-effective vs allogeneic transfusion when blood loss exceeds ~500 mL
• Suitable for Jehovah's Witnesses when circuit is kept continuous
• No risk of transfusion-transmitted infection

• Malignant tumours - risk of re-infusing cancer cells (relative; leucocyte depletion filters may be used selectively)
• Bowel contamination in operative field - bacterial seeding
• Amniotic fluid contamination - amniotic fluid embolism risk (leucocyte filters reduce but do not eliminate risk)
• Use of topical haemostatic agents (thrombin, H₂O₂) in field that contaminate the salvage
• Sickle cell disease (relative)

• Blood collected from drains up to 6 hours post-op in a reservoir, then reinfused
• Used in TKA and THA
• Evidence weaker than IOBS; blood may contain inflammatory mediators, fat globules, activated complement

Comparison of the Three Methods

Role in Orthopaedic Practice

• Total Hip Arthroplasty - expected loss 500-1500 mL; IOBS preferred
• Total Knee Arthroplasty - tourniquet reduces operative loss; postoperative drain salvage most relevant
• Revision Arthroplasty - high blood loss; IOBS strongly indicated
• Spinal instrumentation (scoliosis, lumbar fusion) - IOBS standard of care
• Pelvic/acetabular fractures - IOBS highly effective
• Bone tumour surgery - IOBS with leucocyte filter in selected cases

Current Position

• No preoperative anaemia induction
• No wastage
• Fresh cells with better oxygen-carrying capacity
• More cost-effective
• Comparable or superior blood conservation

1. Preoperative anaemia detection and treatment
2. Intraoperative ABT (cell salvage, ANH) + surgical haemostasis + tranexamic acid
3. Restrictive postoperative transfusion thresholds

• Barash, Cullen & Stoelting's Clinical Anesthesia, 9th ed., pp. 1330-1331
• Sain A et al. Cell Salvager in Orthopaedic Surgery. Georgian Med News 2024
• Feuer G et al. Intraoperative cell salvage in spinal surgery. Spine Deform 2025